Principal Associate Scientist

Ascidian Therapeutics

Posted on: July 2, 2026

Closing: August 01, 2026

Salary: 112,017.00 - 118,400.00 per year

Job Description

(Boston, MA) Principal Associate Scientist sought by Ascidian Therapeutics, Inc. to
design, validate, execute, and interpret experiments to improve therapeutic performance
of designer RNA editing molecules & contribute to characterization of drug candidates to
support Ascidian's Roche Collaboration. Req.'s Master's Deg. in Molecular/Cellular
Bio., Bio. Chem. or rel. field & 3 yrs rel. exp. or Bach's Deg. & 5 yrs rel. exp. Must have
experience in RNA therapeutics with a focus on pre-mRNA splicing and protein
translation; designing and cloning RNA exon-editing molecules and designing assays to
measure RNA editing; optimization and preparation of custom Illumina libraries;
bioinformatic analysis of the libraries; cell culture, ddPCR, qPCR and protein extraction
and characterization by JESS and western blot, Sanger sequence analysis; use of
sequence design and analysis software.

Apply to: https://grnh.se/7figxnp64us

No calls.

Salary: $ 112,017 to $118,400 per year.

The final salary offer will be determined based on several factors, including the candidate's relevant experience, specific skills, and internal equity.

Ascidian Therapeutics

Posted on: July 2, 2026

Closing: August 01, 2026

Salary: 112,017.00 - 118,400.00 per year

Career Focus: Scientist

This role is part of a curated selection of life science opportunities featured on Xtalks. Employers may request edits or removal here.

Similar Jobs


Vista, California, United States

Clinical Laboratory Scientist I

Overview Exagen is a patient-focused and discovery-driven life sciences ...

Wilmington, United States

Associate Scientist

Job Highlights Work closely with the project manager, scientists, and re...

Wilmington, United States

Associate Scientist

Job Highlights Work closely with the project manager, scientists, and re...

Verona, Wisconsin, United States

Associate Scientist III, Quality Control...

Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biop...